Clinical trial
Safety of Dialysate Sodium Individualization in Hemodialysis Patients With…
NCT00237783 · Yale University, Other · Terminated
Key facts
| NCT number | NCT00237783 |
|---|---|
| Title | Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension |
| Official title | Hemodynamic Changes During Dialysate Sodium Individualization in Hemodialysis Patients |
| Lead sponsor | Yale University, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hemodialysis, Hypotension |
| Intervention type | Drug |
| Interventions | dialysate sodium (140 mmol/L), individualized dialysate sodium |
| Enrollment | 4 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Oct 12, 2005 |
| Last update posted | Jul 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: